NCT05530278 - A Study to Assess the Pharmacokinetics and Safety of Co-administered Oral Galicaftor, Navocaftor, and ABBV-576 in Healthy Adults for the Treatment of Cystic Fibrosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 20, 2022

Primary Completion Date

November 29, 2022

Study Completion Date

November 29, 2022

Conditions

Healthy Volunteers

Interventions

DRUG

Galicaftor

Oral

DRUG

ABBV-576

Oral

DRUG

Navocaftor

Oral

DRUG

Midazolam

Oral

Trial Locations (4)

Clinical Pharmacology of Miami /ID# 248823, Miami

PPD Clinical Research Unit - Austin /ID# 248854, Austin

Anaheim Clinical Trials LLC /ID# 248824, Anaheim

PPD Clinical Research Unit -Las Vegas /ID# 248853, Las Vegas